Back to Screener

Healthcare

eXoZymes, Inc.(EXOZ)

Live Price

Offline

$7.40

+3.64% today

1Y Change

-28.78%

Window

Jun 27, 2025 โ†’ Jun 25, 2026

Market Cap
$90.00M
Revenue Growth
0.0%
EPS Growth
-51.4%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 27, 2025 โ†’ Jun 25, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

eXoZymes, Inc. (EXOZ) is a Healthcare stock with a market cap of $90.00M and listed on NASDAQ. The stock last traded around $7.40 and down 28.8% across the available one-year price window (Jun 27, 2025 โ†’ Jun 25, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -51.4%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -51.4%, free cash flow +25.1% with operating margin 0.0% and ROIC -203.1%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines EXOZ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

EXOZ vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

EXOZ

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

EXOZ Max Drawdown

-61.64%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for EXOZ and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 19, 2026Q2
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
Q2
May 19, 26
โœ“
0.34
Est 0.24
+41.7%
โ€”
Est โ€”
โ€”
May 19
Q1
Jan 8, 26
โœ“
0.10
Est 0.07
+42.9%
โ€”
Est โ€”
โ€”
Jan 8
Q4
Oct 13, 25
โœ“
0.03
Est 0.02
+50.0%
โ€”
Est โ€”
โ€”
Oct 13
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.